Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
Status unknown · Phase 4 · NCT04987892
Conditions: BPH
At a glance
- Research payments reported, 2025
- $265,072
- U.S. investigators named
- 12
- Sites paid
- 14
- Planned or actual enrollment
- 250
About the trial
- Sponsor
- NeoTract, Inc.
- Tested
- UroLift System (device), Tamsulosin Hydrochloride (drug)
- Dates
- Started 2021-12-06; completion 2025-10
- Results posted
- Not yet
This prospective, multicenter, two-arm, 1:1 randomized controlled trial (RCT) will enroll approximately 250 males at approximately 25 sites located within the United States. All enrolled subjects will be 45 years of age or older diagnosed with symptomatic benign prostatic hyperplasia (BPH). They will be randomized to one of two readily available, marketed BPH therapies; Prostatic Urethral Lift procedure with the UroLift System (PUL Arm) or 0.4mg tamsulosin HCl (MED Arm).
From ClinicalTrials.gov, last updated 2023-04-25. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Teleflex LLC reported $265,072 in research payments for this study in 2025 (137 payments).
Products named: Urolift
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Todd Bertoch, M.D. Anesthesiology · Prescott, AZ
- Philip P. Brodak, MD Urology · Murrieta, CA
- Prithipal S. Sethi, M.D. Urology · Sacramento, CA
- Sean P. Heron, M.D. Urology · St Petersburg, FL
- Shadi S. Tarazi, M.D., Nephrology (Kidney) · Miami Beach, FL
- William B. Roth, MD Urology · Lafayette, LA
- Sheldon J. Freedman, MD Urology · Las Vegas, NV
- Brian C. Mazzarella, MD Urology · Lakeway, TX
- Claus G. Roehrborn, MD Urology · Dallas, TX
- Michael D. Trotter, M.D. Urology · Austin, TX
- Nilay Gandhi, MD Urology · Woodbridge, VA
- James D. Young, MD Urology · Virginia Beach, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Edward Jenner Urology $103,526
- Urology Austin PLLC $41,513
- Tri Valley Urology Medical Group $27,335
- Southern Urology LLC $24,154
- Midtown Urology $19,578
- Ut Southwestern Medical Center $15,607
- Golden State Urology-Sacramento $10,026
- Advance Urology Institute LLC $8,111
- Potomac Urology Center $4,868
- University of Texas Southwestern Medical Center $3,975
- Golden State Urology-Stockton $2,000
- Sheldon J Freedman MD LTD $1,997
- Urology of Virginia PLLC $1,882
- Jbr Clinical Research LLC $501
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.